Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Medtronic
Johnson and Johnson
Moodys
Merck
AstraZeneca
Boehringer Ingelheim

Last Updated: February 18, 2020

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR CUBICIN RF

See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Cubicin Rf

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00295178 Study Comparing CUBICINĀ® (Daptomycin for Injection) With Vancomycin in Cellulitis or Erysipelas Completed Cubist Pharmaceuticals LLC Phase 4 2006-02-01 This study is designed to investigate the difference in speed and degree of symptom resolution between daptomycin and vancomycin in subjects treated for cellulitis or erysipelas by evaluation of the following parameters: - Time to erythema margin cessation to progress - Time to defervescence - Time to hospital discharge following relief of the presenting cellulitis or erysipelas - Degree of improvement of the following signs and symptom of cellulitis or erysipelas including - Degree of improvement of cellulitis-related pain and swelling as reported by subjects Additionally, the difference in frequency of Adverse Events between daptomycin and vancomycin will be described.
NCT00638157 Phase 4 Efficacy and Safety Study of CubicinĀ® With and Without Combination Therapy in S. Aureus Infective Endocarditis (SAIE) Terminated Cubist Pharmaceuticals LLC Phase 4 2008-03-01 multicenter, randomized, double blind study to describe the safety and efficacy of daptomycin (6 mg/kg q24h) with and without concomitant initial gentamicin combination therapy in the treatment of SAIE
NCT00651131 Cubicin(R) for Complicated Post-Surgical Wound Infections Terminated Cubist Pharmaceuticals LLC Phase 4 2004-06-01 The purpose of the study is to describe the clinical efficacy of CUBICIN therapy in patients with superficial and deep post-surgical Gram-positive wound infections
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Cubicin Rf

Condition Name

Condition Name for Cubicin Rf
Intervention Trials
Diabetic Foot Infection 1
Renal Failure 1
Bacterial Infection 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Cubicin Rf
Intervention Trials
Infection 3
Communicable Diseases 3
Skin Diseases 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Cubicin Rf

Trials by Country

Trials by Country for Cubicin Rf
Location Trials
China 9
United States 9
Canada 1
France 1
Switzerland 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Cubicin Rf
Location Trials
Pennsylvania 2
Michigan 2
Texas 1
Minnesota 1
Oklahoma 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Cubicin Rf

Clinical Trial Phase

Clinical Trial Phase for Cubicin Rf
Clinical Trial Phase Trials
Phase 4 5
Phase 3 2
Phase 1 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Cubicin Rf
Clinical Trial Phase Trials
Completed 4
Terminated 3
Recruiting 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Cubicin Rf

Sponsor Name

Sponsor Name for Cubicin Rf
Sponsor Trials
Cubist Pharmaceuticals LLC 5
University of Oklahoma 1
AstraZeneca 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Cubicin Rf
Sponsor Trials
Industry 6
Other 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKesson
Merck
Baxter
Mallinckrodt
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.